Evaluating Plasma p-tau217 as an Endpoint for Alzheimer Disease Clinical Trials

Computational neuroscientist working at the intersection of machine learning, biomedical imaging, and human genetics in neurodegenerative disease. My work applies deep learning to high-dimensional medical images, harmonizes imaging measurements across sites and acquisition protocols, and integrates imaging with genomic, proteomic, and longitudinal clinical data to characterise Alzheimer’s disease and related dementias, with particular focus on fluid and imaging biomarkers of neurodegeneration.